TY - JOUR
T1 - Barriers to and facilitators of paediatric medical device innovation
T2 - A scoping review protocol
AU - Kysh, Lynn
AU - Zapotoczny, Grzegorz
AU - Manzanete, Lisa
AU - Carey, Megan
AU - Shah, Payal
AU - Joseph, Francesca
AU - Kempf, Haley
AU - Sikder, Abu Taher
AU - Finkel, Julia
AU - Thekkedath, Usha
AU - Toman, Kara
AU - Koh, Chester J.
AU - Eskandanian, Kolaleh
AU - Espinoza, Juan
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2024/6/5
Y1 - 2024/6/5
N2 - Introduction The development of paediatric medical devices continues to lag adult medical devices and contributes to issues of inequity, safety, quality and patient outcomes. New legislation and funding mechanisms have been introduced over the past two decades, but the gap remains. Clinical trials have been identified as a pain point, but components of effective clinical research infrastructure are poorly understood. As part of a multimodal research strategy, the Pediatric Device Consortia (PDC) will conduct a scoping review to better understand infrastructural barriers to and facilitators of paediatric medical device clinical research identified in the health sciences literature. Methods and analysis The following databases will be included for this review: Medline, Embase, Cochrane CENTRAL, Web of Science and IEEE Xplore. Additional grey literature will be sought out through Google Scholar and reviewing the citations of included studies. Included studies will discuss medical devices according to the U.S. Food and Drug Administration classification, focus on the paediatric population (ages 0-21 years) and involve human premarket or postmarket research. All study types that were published in 2007-present in English, Spanish, French or Italian will be included. Using Covidence web-based software, two independent reviewers will screen the resulting titles, abstracts and the full text of potential studies. Conflicts will be resolved by the primary investigator during both phases. REDCap will be used for quantitative and qualitative data charting, generating data tables and narrative synthesis. Ethics and dissemination This research did not require research ethics board consideration as it does not involve human participants and all data will be collected from published literature. We will share our findings through peer-reviewed manuscripts, clinical and research conference presentations and professional networks available to the PDC. Study registration Open Science Framework (https://osf.io/k72bn).
AB - Introduction The development of paediatric medical devices continues to lag adult medical devices and contributes to issues of inequity, safety, quality and patient outcomes. New legislation and funding mechanisms have been introduced over the past two decades, but the gap remains. Clinical trials have been identified as a pain point, but components of effective clinical research infrastructure are poorly understood. As part of a multimodal research strategy, the Pediatric Device Consortia (PDC) will conduct a scoping review to better understand infrastructural barriers to and facilitators of paediatric medical device clinical research identified in the health sciences literature. Methods and analysis The following databases will be included for this review: Medline, Embase, Cochrane CENTRAL, Web of Science and IEEE Xplore. Additional grey literature will be sought out through Google Scholar and reviewing the citations of included studies. Included studies will discuss medical devices according to the U.S. Food and Drug Administration classification, focus on the paediatric population (ages 0-21 years) and involve human premarket or postmarket research. All study types that were published in 2007-present in English, Spanish, French or Italian will be included. Using Covidence web-based software, two independent reviewers will screen the resulting titles, abstracts and the full text of potential studies. Conflicts will be resolved by the primary investigator during both phases. REDCap will be used for quantitative and qualitative data charting, generating data tables and narrative synthesis. Ethics and dissemination This research did not require research ethics board consideration as it does not involve human participants and all data will be collected from published literature. We will share our findings through peer-reviewed manuscripts, clinical and research conference presentations and professional networks available to the PDC. Study registration Open Science Framework (https://osf.io/k72bn).
KW - Clinical trials
KW - Health Equity
KW - Health policy
KW - PAEDIATRICS
UR - http://www.scopus.com/inward/record.url?scp=85195348531&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195348531&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2023-081541
DO - 10.1136/bmjopen-2023-081541
M3 - Article
C2 - 38839390
AN - SCOPUS:85195348531
SN - 2044-6055
VL - 14
JO - BMJ open
JF - BMJ open
IS - 6
M1 - e081541
ER -